MedPacto, Inc. (235980.KQ)
KRW 4585.0
(-1.4%)
KRW 4585.0
(-1.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -64 Billion KRW | -192.49% |
| 2022 | 69.19 Billion KRW | -6.89% |
| 2021 | 74.31 Billion KRW | 3651.22% |
| 2020 | -2.09 Billion KRW | -434.61% |
| 2019 | 625.35 Million KRW | -62.0% |
| 2018 | 1.64 Billion KRW | -62.28% |
| 2017 | 4.36 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Billion KRW | 113.14% |
| 2024 Q1 | -14.4 Billion KRW | 77.49% |
| 2023 Q3 | 7.79 Billion KRW | -11.71% |
| 2023 FY | -64 Billion KRW | -192.49% |
| 2023 Q4 | -64 Billion KRW | -921.21% |
| 2023 Q2 | 8.82 Billion KRW | 0.28% |
| 2023 Q1 | 8.8 Billion KRW | -87.28% |
| 2022 Q4 | 69.19 Billion KRW | 3.54% |
| 2022 Q2 | 62.11 Billion KRW | 8.37% |
| 2022 FY | 69.19 Billion KRW | -6.89% |
| 2022 Q1 | 57.31 Billion KRW | -22.87% |
| 2022 Q3 | 66.82 Billion KRW | 7.59% |
| 2021 Q4 | 74.31 Billion KRW | 1.48% |
| 2021 Q1 | 68.27 Billion KRW | 2636.38% |
| 2021 Q2 | 71.33 Billion KRW | 4.48% |
| 2021 FY | 74.31 Billion KRW | 3651.22% |
| 2021 Q3 | 73.22 Billion KRW | 2.66% |
| 2020 Q4 | -2.69 Billion KRW | 0.0% |
| 2020 FY | -2.09 Billion KRW | -434.61% |
| 2019 FY | 625.35 Million KRW | -62.0% |
| 2018 FY | 1.64 Billion KRW | -62.28% |
| 2017 FY | 4.36 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Co., Ltd. | -46.18 Billion KRW | -38.579% |
| iNtRON Biotechnology, Inc. | -40.58 Billion KRW | -57.696% |
| BINEX Co., Ltd. | 45.34 Billion KRW | 241.134% |
| Bioneer Corporation | -3.9 Billion KRW | -1537.768% |
| Anterogen.Co.,Ltd. | 8.35 Billion KRW | 866.309% |
| MEDIPOST Co., Ltd. | 14.81 Billion KRW | 532.018% |
| CrystalGenomics, Inc. | 8.99 Billion USD | 811.757% |
| Helixmith Co., Ltd | -24.42 Billion KRW | -162.02% |
| Chabiotech Co.,Ltd. | 388.94 Billion KRW | 116.455% |
| Medy-Tox Inc. | 49.58 Billion KRW | 229.074% |
| Peptron, Inc. | 4.86 Billion KRW | 1414.549% |
| Amicogen, Inc. | 125.26 Billion KRW | 151.093% |
| Genexine, Inc. | 61.39 Billion KRW | 204.243% |
| HLB Therapeutics Co.,Ltd. | -13.68 Billion KRW | -367.608% |
| LegoChem Biosciences, Inc. | -56.05 Billion KRW | -14.177% |
| ALTEOGEN Inc. | 53.56 Billion KRW | 219.471% |
| PharmaResearch Co., Ltd. | -32.93 Billion KRW | -94.304% |
| SillaJen, Inc. | -13.89 Billion KRW | -360.714% |
| JETEMA, Co., Ltd. | 84.27 Billion KRW | 175.939% |
| OliX Pharmaceuticals,Inc | 27.37 Billion KRW | 333.794% |
| Genomictree Inc. | -43.43 Billion KRW | -47.347% |
| D&D Pharmatech | -7.5 Billion KRW | -752.453% |
| EASY BIO,Inc. | 53.21 Billion KRW | 220.278% |
| GI Innovation, Inc. | -4.82 Billion KRW | -1227.121% |